openPR Logo
Press release

Bioprocess Validation Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2027

01-25-2021 10:20 AM CET | Health & Medicine

Press release from: Allied Market Research

Bioprocess Validation Market

Bioprocess Validation Market

The bioprocess validation market size was valued at $0.26 billion in 2019 and is projected to reach $0.41 billion by 2027, registering a CAGR of 5.5% from 2020 to 2027.

Bioprocess validation is a method of building documentary evidence demonstrating a process, activity or procedure, carried out in production or testing maintains the desired level of compliance at all stages. Validation is an act of documenting and demonstrating that any process, procedure, and activity will consistently produce the required results. The production process within the pharmaceutical industry undergoes a series of recalls, reworks, and product failures. This factor necessitates the presence of a system to evaluate the viability of an experiment or product development channel.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/8357

Furthermore, pharmaceutical manufacturing is now being outsourced to third party service providers for higher production yields. Disposable technology is being widely used in drug development for bringing down production costs. Disposable technology is facilitating the full integration of pharmaceutical production for consistent products while consuming fewer resources. This has made it necessary to establish an ongoing monitoring process that ensures strict adherence to regulatory compliance. In addition, Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) as a strategy to stay competitive and flexible in a world of exponentially growing knowledge, increasingly sophisticated technologies and an unstable economic environment.

The bioprocess validation market is positively impacted by the COVID-19 pandemic. Several pharmaceutical and & biotechnological companies use validation services for at least some of their bioprocessing. The bioprocessing sector is experiencing operational and personnel-related problems, but often these are related to increased activity. Essentially, all bioprocessing-related industrial activities are continuing largely unaffected in terms of operations and output. Many bioprocessing processes are being leveraged for the development of vaccines against coronaviruses. For instance, many companies, including developers and suppliers of services are increasing their pandemic-related R&D and manufacturing. Many suppliers of both equipment and services have begun increasing their activities in response to this increase, and to projected demand. The coronavirus disease could affect the global economy through three channels such as direct impact on production, supply chain & market disruption, and financial impact on firms & financial markets. In addition, this pandemic has affected the effect on production and import & export of finished goods, due to shutdown in various COVID-19-affected countries.

The bioprocess validation market witnesses rapid growth due to stringent safety & quality regulations, increase in demand for biopharmaceuticals, and surge in demand for outsourcing bioprocess validation. In addition, increase in life science R&D expenditure is expected to fuel the bioprocess validation market growth. However, issues related to extractables are expected to impede this growth. On the contrary, patent expiry of bio-product is expected to present various opportunities for the market expansion.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/8357

In terms of test type, the extractables testing services segment dominated the bioprocess validation market in 2019. The large share of this segment can be attributed to the presence of regulatory mandates and guidelines regarding the testing of extractables; increasing outsourcing of testing services by biopharmaceutical manufacturers; growing requirement for product safety, identity, purity, and quality; and increasing risk of product adulteration.

The pharmaceutical & biopharmaceutical companies segment is projected to grow at the highest CAGR of 5.8% during the forecast period, owing to increase in production of biopharmaceuticals & consistent increase in the number of impurities to be checked along with the stringency of standards & regulations regarding the quality and validity of bioprocesses involved in the production.

The Major Key Players Are:

Cobetter Filtration Equipment Co., Ltd, Danher Corporation, Merck KGaA, Porvair Plc, Sartorius, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc, Toxikon Corporation, Almac Group, and Biozeen.

Key findings of the study:

• By test type, the extractables testing services segment occupied 39.7% share of the bioprocess validation market in 2019.
• By end user, the pharmaceutical & biotechnology companies segment occupied 69.0% share of the bioprocess validation market in 2019.
• By region, Asia Pacific is anticipated to experience growth at 7.1% CAGR during the forecast period.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioprocess Validation Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2027 here

News-ID: 2230542 • Views:

More Releases from Allied Market Research

Nanosatellite and Microsatellite Market Share Reach USD 8.69 Billion by 2030
Nanosatellite and Microsatellite Market Share Reach USD 8.69 Billion by 2030
𝐍𝐚𝐧𝐨𝐬𝐚𝐭𝐞𝐥𝐥𝐢𝐭𝐞 𝐚𝐧𝐝 𝐌𝐢𝐜𝐫𝐨𝐬𝐚𝐭𝐞𝐥𝐥𝐢𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 by End User (Civil, Government, Commercial, and Military), Application (Communications, Earth Observation, Space Science, Technology Demonstration, and Technology Development), and Orbit Type (Non-Polar Inclined, Polar, and Sun-Synchronous): Global Opportunity Analysis and Industry Forecast, 2021-2030." As per the report, the global nanosatellite and microsatellite industry was accounted for $2.23 billion in 2020, and is expected to reach $8.69 billion by 2030, growing at a CAGR of 14.9%
Anti-Drone Market is experiencing significant growth and is anticipated to attain a CAGR of 27.9% by the year 2031
Anti-Drone Market is experiencing significant growth and is anticipated to attai …
𝐀𝐧𝐭𝐢-𝐃𝐫𝐨𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 by Technology (Electronic System, Laser System, Kinetic System), by Application (Detection, Disruption), by End Use (Government, Military & Defense, Commercial), by Platform (Ground, Handheld, UAV Based): Global Opportunity Analysis and Industry Forecast, 2021- 2031". According to the report, the global anti-drone industry generated $1.3 billion in 2021 and is anticipated to generate $14.6 billion by 2031, witnessing a CAGR of 27.9% from 2022 to 2031. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐍𝐨𝐰:
Home Exercise Bike Market is expected to witness robust Compound Annual Growth Rate (CAGR) progress of 8.7% from 2021 to 2027.
Home Exercise Bike Market is expected to witness robust Compound Annual Growth R …
According to a new report published by Allied Market Research, titled, "Home Exercise Bike Market by Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," The global home exercise bike market size was valued at $1,213.5 million in 2019, and is projected to reach $2,335.2 million by 2027, registering a CAGR of 8.7% from 2021 to 2027. The recumbent segment is expected to retain its dominant position, in terms
Rapidly expanding entertainment products industry is set to drive the growth of the $103.8 billion Toys market ; Ravensburger AG, Tomy Company, Ltd, Vtech Holdings, and Thames & Kosmos.
Rapidly expanding entertainment products industry is set to drive the growth of …
According to a new report published by Allied Market Research, titled, "Toys Market by Product Type, Age Group and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," the toys market size was $92.2 billion in 2019, and is projected reach $103.8 billion by 2027, registering a CAGR of 2.5% from 2021 to 2027. The increase in number of games bars, cafes and family entertainment centers worldwide is boosting the demand for

All 5 Releases


More Releases for Bioprocess

Bioprocess Technology Market 2022 | Detailed Report
The Bioprocess Technology report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Bioprocess Technology research report recognizes and gets fundamental
Bioprocess Validation Market Report Up to 2031
Visiongain has published a new report on Bioprocess Validation Market Report : Forecasts by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End User (Biotechnology & Pharmaceutical Companies). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/bioprocess-validation-market-2021/#download_sampe_div Validation is a method of building documentary evidence demonstrating a process, activity or procedure, carried
Global Bioprocess Bags Market Analysis (2020-2025)
Global Info Research offers a latest published report on Bioprocess Bags Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Bioprocess Bags Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515903/bioprocess-bags Market
Bioprocess Containers Market Professional Survey Report
This report studies the global Bioprocess Containers market status and forecast, categorizes the global Bioprocess Containers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Bioprocess Containers are ready-to-use, single-use flexible container systems commonly for critical sterile liquid-handling applications in the
Bioprocess Antifoam Market - Lucrative Opportunities Across Globe
Chemical antifoaming agents are used for the destruction of excessive foam in biological processes. This is because foaming can transform into major problem at the time of large-scale recombinant protein bioprocesses. Antifoams are available in several forms with a range of properties and varied foam destruction capabilities, with the ones needed several times becoming depleted over time. Get Brochure for Latest Advancements and Research Insights @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15233 Antifoaming agents may contain surfactants
Bioprocess Technology Market - Comprehensive Evaluation by 2025
Global Bioprocess Technology Market: Snapshot Bioprocess technology is a vital part of biotechnology that deals with processes combining the complete living matter or its components with nutrients to make specialty chemicals, reagents, and biotherapeutics. The processes form the backbone of translating discoveries of life sciences into useful industrial products. Various stages associated with the bioprocess technology include substrates and media, biocatalysts, volume production, downstream processing, purification, and final processing. Over the